{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:28:45Z","timestamp":1744802925258},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Erectile dysfunction (ED), for multifactorial reasons, is one of the biggest current quandaries among men worldwide and results in other complications such as reduced quality of life of the patient and his sexual partner, impotence, and psychiatric problems.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Understanding of disease etiology, penile anatomy, erectile physiology, therapeutic mechanisms, and effective molecular pathways all play key roles in determining a therapeutic approach. This project is based on the study of topical minoxidil\u2019s effectiveness in treating ED.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To perform a comprehensive overview of the subject, we performed a triple-keyword combination search to assess recent studies of ED.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The most common formulation used in these studies was 2% minoxidil solution. Except for cases studied in paralytic patients, topical treatment with minoxidil appears to elicit a mild erectile response; however, this finding is insufficient to confirm the effectiveness of this topical treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although evidence to confirm the therapeutic properties of minoxidil in ED is limited, combination therapy and the use of modern formulations of minoxidil are promising options for treating ED in the future.<\/jats:p><\/jats:sec>","DOI":"10.1093\/sxmrev\/qead001","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T18:13:25Z","timestamp":1677694405000},"page":"114-123","source":"Crossref","is-referenced-by-count":4,"title":["Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil"],"prefix":"10.1093","volume":"11","author":[{"given":"Marziye Ranjbar","family":"Tavakoli","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Faraji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Sam","sequence":"additional","affiliation":[{"name":"Student Research Committee, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ghasempour","sequence":"additional","affiliation":[{"name":"Student Research Committee, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Langarizadeh","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayyeh","family":"Karami-Mohajeri","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences , Kerman , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1098-3597(05)80043-2","article-title":"Characterisation, prevalence, and consultation rates of erectile dysfunction","volume":"7","author":"Dean","year":"2005","journal-title":"Clin Cornerstone"},{"issue":"1","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ju.0000164463.19239.19","article-title":"Chapter 1: the management of erectile dysfunction: an AUA update","volume":"174","author":"Montague","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jsm.12023","article-title":"SOP conservative (medical and mechanical) treatment of erectile dysfunction","volume":"10","author":"Porst","year":"2013","journal-title":"J Sex Med"},{"issue":"8","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1743-6109.2008.00773.x","article-title":"British Society for Sexual Medicine guidelines on the management of erectile dysfunction","volume":"5","author":"Hackett","year":"2008","journal-title":"J Sex Med"},{"issue":"3","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/10790268.1996.11719430","article-title":"Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers","volume":"19","author":"Watanabe","year":"1996","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2165\/00002512-199711020-00006","article-title":"Drugs for the treatment of impotence","volume":"11","author":"Garcia-Reboll","year":"1997","journal-title":"Drugs Aging"},{"key":"2023040311444825400_","first-page":"1","article-title":"Physiology of penile erection and pathophysiology of erectile dysfunction","author":"Leung","year":"2004","journal-title":"Atlas of Male Sexual Dysfunction"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14656566.2.1.95","article-title":"The role of nitric oxide in penile erection","volume":"2","author":"Cartledge","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4065\/74.7.709","article-title":"Pharmacotherapeutic advances in the treatment of erectile dysfunction","volume":"74","author":"Nehra","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"2023040311444825400_","first-page":"197","article-title":"Extending the rationale of combination therapy to unresponsive erectile dysfunction","volume":"9","author":"Reece","year":"2007","journal-title":"Rev Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11934-000-0012-6","article-title":"Oral and injectable medications for the treatment of erectile dysfunction","volume":"1","author":"Carson","year":"2000","journal-title":"Curr Urol Rep"},{"issue":"6","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0022-5347(17)41342-5","article-title":"Acetylcholine as a possible neurotransmitter in penile erection","volume":"141","author":"Stief","year":"1989","journal-title":"J Urol"},{"key":"2023040311444825400_","first-page":"159","article-title":"Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells","volume":"5","author":"Traish","year":"1995","journal-title":"Receptor"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/03331024211037304","article-title":"Could erectile dysfunction be a side effect of CGRP inhibition? A case report","volume":"42","author":"Al-Hassany","year":"2022","journal-title":"Cephalalgia"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jsxm.2016.02.082","article-title":"Separate or combined treatments with human bone marrow-derived stem cells and substance P of erectile dysfunction in a rat model of diabetes","volume":"13","author":"Song","year":"2016","journal-title":"J Sex Med"},{"issue":"4","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1111\/j.1476-5381.1995.tb15062.x","article-title":"Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum","volume":"116","author":"Hedlund","year":"1995","journal-title":"Br J Pharmacol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00005392-199502000-00072","article-title":"Characterization and function of histamine receptors in corpus cavernosum","volume":"153","author":"Kim","year":"1995","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1464-410X.1995.tb07315.x","article-title":"The role of histamine in human penile erection","volume":"75","author":"Car\u00e1","year":"1995","journal-title":"Br J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/pr.111.004515","article-title":"Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction","volume":"63","author":"Andersson","year":"2011","journal-title":"Pharmacol Rev"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0149-7634(00)00023-3","article-title":"Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine","volume":"24","author":"Heaton","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1532-5415.2005.53022.x","article-title":"From aspiration to achievement: assessment and noninvasive treatment of erectile dysfunction in aging men","volume":"53","author":"Seftel","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuroscience.2008.08.032","article-title":"The septal area, site for the central regulation of penile erection during waking and rapid eye movement sleep in rats: a stimulation study","volume":"156","author":"Gulia","year":"2008","journal-title":"Neuroscience"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1528-1157.1996.tb00555.x","article-title":"Nocturnal penile tumescence and rigidity evaluation in men with epilepsy","volume":"37","author":"Guldner","year":"1996","journal-title":"Epilepsia"},{"issue":"5","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1464-410X.2003.04093.x","article-title":"Pharmacological management of erectile dysfunction","volume":"91","author":"Montorsi","year":"2003","journal-title":"BJU Int"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/978-1-4612-1848-7_33","volume-title":"Oral, Transdermal, and Transurethral Therapies for Erectile Dysfunction. Male Infertility and Sexual Dysfunction","author":"Doherty","year":"1997"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/1008-682X.139253","article-title":"Evaluation of young men with organic erectile dysfunction","volume":"17","author":"Papagiannopoulos","year":"2015","journal-title":"Asian J Androl"},{"key":"2023040311444825400_","first-page":"88","article-title":"The treatment of erectile dysfunction in patients with neurogenic disease","volume":"5","author":"Shridharani","year":"2016","journal-title":"Transl Androl Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2165\/00003495-200565120-00003","article-title":"A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?","volume":"65","author":"Hatzimouratidis","year":"2005","journal-title":"Drugs"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/01.ju.0000067820.86347.95","article-title":"Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment","volume":"169","author":"Seftel","year":"2003","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S0959259809990384","article-title":"Sexual dysfunction in the older man","volume":"19","author":"Albersen","year":"2009","journal-title":"Rev Clin Gerontol"},{"issue":"5","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2006.01.028","article-title":"EAU Guidelines on erectile dysfunction: an update","volume":"49","author":"Wespes","year":"2006","journal-title":"Eur Urol"},{"key":"2023040311444825400_","first-page":"407","article-title":"Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction","volume":"38","author":"Huang","year":"2013","journal-title":"P T"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/1060028013501989","article-title":"Avanafil for erectile dysfunction","volume":"47","author":"Kyle","year":"2013","journal-title":"Ann Pharmacother"},{"key":"2023040311444825400_","first-page":"8:517-523","article-title":"Avanafil for treatment of erectile dysfunction: review of its potential","author":"Evans","year":"2012","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.sxmr.2022.02.002","article-title":"A review on phosphodiesterase-5 inhibitors as a topical therapy for erectile dysfunction","volume":"10","author":"Hamzehnejadi","year":"2022","journal-title":"Sex Med Rev"},{"issue":"S1","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/sj.ijir.3900808","article-title":"Current status of local penile therapy","volume":"14","author":"Montorsi","year":"2002","journal-title":"Int J Impot Res"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/1-59259-871-4:253","volume-title":"Intracavernous, Transurethral, and Topical Therapies for Erectile Dysfunction in the Era of Oral Pharmacotherapy. Oral Pharmacotherapy for Male Sexual Dysfunction","author":"Fritsche","year":"2005"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.sc.3100361","article-title":"Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions","volume":"35","author":"Renganathan","year":"1997","journal-title":"Spinal Cord"},{"key":"2023040311444825400_","first-page":"4","article-title":"Treatment options for male erectile dysfunction: a systematic review of published studies of effectiveness","author":"Wilt","year":", . 2001","journal-title":"Database of Abstracts of Reviews of Effects (DARE)"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/21548331.1997.11443467","article-title":"Advances in the treatment of organic erectile dysfunction","volume":"32","author":"Kim","year":"1997","journal-title":"Hosp Pract"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.ijir.3901145","article-title":"Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan)","volume":"16","author":"Usta","year":"2004","journal-title":"Int J Impot Res"},{"issue":"10","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ndt\/15.10.1525","article-title":"Nephrology dialysis transplantation end-stage renal disease and erectile dysfunction. Is there any hope?","volume":"15","author":"Ayub","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1043-2760(97)00012-X","article-title":"Impotence in diabetes","volume":"8","author":"Robinson","year":"1997","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0090-4295(02)01980-5","article-title":"Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program","volume":"60","author":"Steidle","year":"2002","journal-title":"Urology"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.ijir.3900940","article-title":"The efficacy and safety of a topical alprostadil cream, Alprox-TD\u00ae, for the treatment of erectile dysfunction: 2 phase 2 studies in mild-to-moderate and severe ED","volume":"15","author":"Padma-Nathan","year":"2003","journal-title":"Int J Impot Res"},{"issue":"4","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.sxmr.2022.06.004","article-title":"Prostaglandins as a topical therapy for erectile dysfunction: a comprehensive review","volume":"10","author":"Hamzehnejadi","year":"2022","journal-title":"Sex Med Rev"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756287216644116","article-title":"Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience","volume":"8","author":"Cuzin","year":"2016","journal-title":"Ther Adv Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/13685530400016540","article-title":"Testosterone therapy in erectile dysfunction","volume":"7","author":"Shabsigh","year":"2004","journal-title":"Aging Male"},{"key":"2023040311444825400_","first-page":"179","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","author":"Shabsigh","year":"2008","journal-title":"J Urol"},{"key":"2023040311444825400_","first-page":"217","article-title":"Topical Testosterone Gel for the Treatment of Male Hypogonadism","volume-title":"Clin Med Insights Ther.","author":"Udeoji","year":"2012"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3109\/03639045.2011.633262","article-title":"Systemic enhancement of papaverine transdermal gel for erectile dysfunction","volume":"38","author":"Wen","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005392-199502000-00019","article-title":"Papaverine topical gel for treatment of erectile dysfunction","volume":"153","author":"Kim","year":"1995","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-5347(17)35742-7","article-title":"Nitroglycerin ointment in the treatment of impotence","volume":"150","author":"Nunez","year":"1993","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","article-title":"Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and Photopulse plethysmography","volume":"82","author":"Wester","year":"1984","journal-title":"J Investig Dermatol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/ijd.13620","article-title":"The use of topical minoxidil to accelerate nail growth: a pilot study","volume":"56","author":"Aiempanakit","year":"2017","journal-title":"Int J Dermatol"},{"key":"2023040311444825400_","volume-title":"Standard Practice in Sexual Medicine","author":"Porst","year":"2008"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1254\/jjp.89.101","article-title":"Pharmacological aspects of erectile dysfunction","volume":"89","author":"Thomas","year":"2002","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1743-6109.2004.04021.x","article-title":"Pharmacotherapy for erectile dysfunction","volume":"1","author":"Padma-Nathan","year":"2004","journal-title":"J Sex Med"},{"key":"2023040311444825400_","volume-title":"Erectile Dysfunction: Issues in Current Pharmacotherapy","author":"Morales","year":"1998"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00005392-199909010-00025","article-title":"Topical prostaglandin E1 SEPA gel for the treatment of erectile dysfunction","volume":"162","author":"McVary","year":"1999","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0022-5347(01)67323-3","article-title":"Topical prostaglandin-E1 for the treatment of erectile dysfunction","volume":"153","author":"Kim","year":"1995","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0022-5347(17)35217-5","article-title":"Topical minoxidil in the treatment of male erectile dysfunction","volume":"151","author":"Radomski","year":"1994","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1468-3083.1994.tb00078.x","article-title":"Practical management of erectile dysfunction","volume":"3","author":"Armstrong","year":"1994","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0031-6865(98)00007-7","article-title":"Effect of vehicles on yohimbine permeation across excised hairless mouse skin","volume":"73","author":"Carelli","year":"1998","journal-title":"Pharm Acta Helv"},{"key":"2023040311444825400_","first-page":"299","article-title":"Topical treatment of erectile dysfunction. Possibilities and perspectives","volume":"67","author":"Pastorini","year":"1995","journal-title":"Arch Ital Urol Androl"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-155-0","volume-title":"Male Sexual Function: A Guide to Clinical Management","author":"Mulcahy","year":"2006"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02547899","article-title":"Medical treatment of neurogenic impotence","volume":"12","author":"Basile","year":"1994","journal-title":"Sex Disabil"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yjmcc.2005.04.006","article-title":"KATP channel therapeutics at the bedside","volume":"39","author":"Jahangir","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-5347(17)37712-1","article-title":"Minoxidil versus nitroglycerin: a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence","volume":"146","author":"Cavallini","year":"1991","journal-title":"J Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0025-7125(16)30076-1","article-title":"Assessment and treatment of impotence","volume":"79","author":"O\u2019Keefe","year":"1995","journal-title":"Med Clin N Am"},{"key":"2023040311444825400_","first-page":"205","article-title":"Minoxidil versus nitroglycerine: a prospective, double-blind, controlled trial in transcutaneous therapy for organic impotence","volume":"6","author":"Cavallini","year":"1994","journal-title":"Int J Impot Res"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00224490009552043","article-title":"Pharmacotherapy in the treatment of male sexual dysfunction","volume":"37","author":"Rowland","year":"2000","journal-title":"J Sex Res"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0272-7358(96)00032-3","article-title":"Erectile dysfunction: the medicalization of male sexuality","volume":"16","author":"Rosen","year":"1996","journal-title":"Clin Psychol Rev"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0090-4295(94)90081-7","article-title":"Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury","volume":"43","author":"Chancellor","year":"1994","journal-title":"Urology"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.sc.3101198","article-title":"Sexual function in spinal cord lesioned men","volume":"39","author":"Biering-S\u00f8rensen","year":"2001","journal-title":"Spinal Cord"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1038\/sj.ijir.3900583","article-title":"Developmental status of topical therapies for erectile and ejaculatory dysfunction","volume":"12","author":"Morales","year":"2000","journal-title":"Int J Impot Res"},{"key":"2023040311444825400_","first-page":"27","article-title":"Transcutaneous minoxidil in the treatment of erectile dysfunctions in spinal cord injured men","volume":"24","author":"Beretta","year":"1993","journal-title":"Acta Eur Fertil"},{"issue":"8","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.sc.3101880","article-title":"Male erectile dysfunction following spinal cord injury: a systematic review","volume":"44","author":"DeForge","year":"2006","journal-title":"Spinal Cord"},{"issue":"10","key":"2023040311444825400_","first-page":"1058","article-title":"Vacuum constriction device and topical minoxidil for management of impotence","volume":"48","author":"Cecchi","year":"1995","journal-title":"Arch Esp Urol"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ijir.2010.4","article-title":"Vacuum therapy in erectile dysfunction-science and clinical evidence","volume":"22","author":"Yuan","year":"2010","journal-title":"Int J Impot Res"},{"issue":"2","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0094-0143(05)70143-9","article-title":"Intracavernosal injection and intraurethral therapy for erectile dysfunction","volume":"28","author":"Leungwattanakij","year":"2001","journal-title":"Urol Clin N Am"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11934-002-0100-x","article-title":"Topical agents and erectile dysfunction: is there a place?","volume":"3","author":"Yap","year":"2002","journal-title":"Curr Urol Rep"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10790268.1995.11719404","article-title":"Erectile response to topical, intraurethral and intracorporal pharmacotherapy in a rat model of spinal cord injury","volume":"18","author":"Rivas","year":"1995","journal-title":"J Spinal Cord Med"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-5491.1990.tb01438.x","article-title":"The Diabetes Physician and an Assessment and Treatment Programme for Male Erectile Impotence","volume-title":"Diabetic Med.","author":"Alexander","year":"1990"},{"key":"2023040311444825400_","first-page":"213","article-title":"Pharmacotherapy of sexual dysfunctions: current status","volume":"46","author":"Avasthi","year":"2004","journal-title":"Indian J Psychiatry"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.seizure.2003.12.006","article-title":"Epilepsy and erectile dysfunction: a review","volume":"13","author":"Smaldone","year":"2004","journal-title":"Seizure"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4158\/EP.9.1.77","article-title":"Medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple\u2019s problem\u20142003 update","volume":"9","author":"Endocrinologists AA of C","year":"2003","journal-title":"Endocr Pract"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/157488911794079082","article-title":"Current and future therapies of erectile dysfunction in neurological disorders","volume":"6","author":"Calabr\u00f2","year":"2011","journal-title":"Recent Pat CNS Drug Discov"},{"key":"2023040311444825400_","first-page":"1187","article-title":"Erectile dysfunction: which medical option for which patient?","volume":"46","author":"Rivera","year":"2006","journal-title":"Consultant"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/1468199021000017236","article-title":"Pharmacotherapy of erectile dysfunction","volume":"17","author":"Pryor","year":"2002","journal-title":"Sex Relatsh Ther"},{"issue":"1","key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2009.01627.x","article-title":"Pharmacotherapy for erectile dysfunction","volume":"7","author":"Eardley","year":"2010","journal-title":"J Sex Med"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1111\/j.1743-6109.2010.02105.x","article-title":"Case study: erectile dysfunction following spinal cord injury (CME)","volume":"7","author":"Elliott","year":"2010","journal-title":"J Sex Med"},{"key":"2023040311444825400_","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17756\/nwj.2016-030","article-title":"Ethanol based vesicular carriers in transdermal drug delivery: nanoethosomes and transethosomes in focus","volume":"2","author":"Kumar","year":"2016","journal-title":"NanoWorld J"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/11\/2\/114\/49729833\/qead001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/11\/2\/114\/49729833\/qead001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T02:36:47Z","timestamp":1702003007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/11\/2\/114\/7059570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,28]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qead001","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2023,2,28]]}}}